Latest On Citius Pharmaceuticals, Inc (CTXR):
About Citius Pharmaceuticals, Inc (CTXR):
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
General
- Name Citius Pharmaceuticals, Inc
- Symbol CTXR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 10
- Last Split Factor1:15
- Last Split Date2017-06-09
- Fiscal Year EndSeptember
- IPO Date2017-07-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.citiuspharma.com
Valuation
- Forward PE 1.29
- Price/Book (Most Recent Quarter) 9.93
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.34
- Next Year EPS Estimate $0.31
- Next Quarter EPS Estimate $0.16
- Return on Assets -44%
- Return on Equity -93%
- Earnings Per Share -$0.82
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 242.77 million
- EBITDA -15601637
- Analyst Target Price $6
- Book Value Per Share $0.45
Share Statistics
- Shares Outstanding 125.79 million
- Shares Float 67.62 million
- % Held by Insiders 2215%
- % Held by Institutions 13.89%
- Shares Short 10.11 million
- Shares Short Prior Month 2.8 million
- Short Ratio 0.37
- Short % of Float 9%
- Short % of Shares Outstanding 8%
Technicals
- Beta 1.55
- 52 Week High $2.5
- 52 Week Low $0.44
- 50 Day Moving Average 1.72
- 200 Day Moving Average 1.21
Dividends
- Dividend Date 2017-06-09
- ExDividend Date N/A
- Dividend Yield 0%
Citius Pharmaceuticals, Inc (CTXR) Dividend Calendar:
CTXR's last dividend payment was made to shareholders on June 9, 2017.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Citius Pharmaceuticals, Inc (CTXR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-03 | $N/A | -$0.15 | $0.16 | -193.75% |
2020-09-30 | 2020-12-16 | $N/A | -$0.07 | -$0.10 | 30% |
2020-06-30 | 2020-08-14 | $N/A | -$0.11 | -$0.11 | 0% |
2020-03-31 | 2020-05-14 | $N/A | -$0.13 | -$0.11 | -18.18% |
2019-12-31 | 2020-02-13 | $N/A | -$0.15 | -$0.14 | -7.14% |
2019-09-30 | 2019-12-16 | $N/A | -$0.16 | -$0.14 | -14.29% |
2019-06-30 | 2019-08-14 | $N/A | -$0.20 | ||
2019-03-31 | 2019-05-15 | $N/A | -$0.20 | -$0.20 | 0% |
2018-12-31 | 2019-02-14 | $N/A | -$0.22 | -$0.21 | -4.76% |
2018-09-30 | 2018-12-11 | $N/A | -$0.15 | ||
2018-06-30 | 2018-08-14 | $N/A | -$0.19 | -$0.32 | 40.63% |
2018-03-31 | 2018-05-11 | $N/A | -$0.44 | ||
2017-12-31 | 2018-03-20 | $N/A | -$0.38 | ||
2017-09-30 | 2017-12-13 | $N/A | -$0.44 | ||
2017-06-30 | 2017-06-30 | $N/A | -$0.49 | ||
2017-03-31 | 2017-03-31 | $N/A | -$0.55 | ||
2016-12-31 | 2016-12-31 | $N/A | -$0.44 | ||
2016-09-30 | 2016-09-30 | $N/A | -$0.53 | ||
2016-06-30 | 2016-06-30 | $N/A | -$0.75 | ||
2016-03-31 | 2016-03-31 | $N/A | -$0.35 | ||
2015-12-31 | 2015-12-31 | $N/A | -$0.53 | ||
2015-09-30 | 2015-09-30 | $N/A | -$0.40 | ||
2015-06-30 | 2015-06-30 | $N/A | -$0.38 | ||
2015-03-31 | 2015-03-31 | $N/A | -$0.17 | ||
2014-12-31 | 2014-12-31 | $N/A | -$0.41 |
Citius Pharmaceuticals, Inc (CTXR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Citius Pharmaceuticals, Inc (CTXR) Chart:
Citius Pharmaceuticals, Inc (CTXR) News:
Below you will find a list of latest news for Citius Pharmaceuticals, Inc (CTXR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Citius Pharmaceuticals, Inc (CTXR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2025-04-17 | 0.5 | 0 | CALL | 0 | 0 | 552.69 | TRUE | 0 | 0 |
2025-04-17 | 1 | 0 | CALL | 0 | 0 | 231.43 | TRUE | 0 | 0 |
2025-04-17 | 1.5 | 0.29 | CALL | 21 | 25 | 190.81 | TRUE | 0.29 | 0 |
2025-04-17 | 2 | 0.14 | CALL | 11 | 17 | 197.11 | FALSE | 0.14 | 0 |
2025-04-17 | 2.5 | 0.06 | CALL | 1 | 25 | 192.2 | FALSE | 0.06 | 0 |
2025-04-17 | 5 | 0 | CALL | 0 | 0 | 285.09 | FALSE | 0 | 0 |
2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 560.8 | FALSE | 0 | 0 |
2025-04-17 | 0.5 | 0.05 | PUT | 30 | 1 | 432.87 | FALSE | 0.05 | 0 |
2025-04-17 | 1 | 0 | PUT | 0 | 0 | 160.24 | FALSE | 0 | 0 |
2025-04-17 | 1.5 | 0.23 | PUT | 31 | 116 | 185.73 | FALSE | -0.02 | -0.08 |
2025-04-17 | 2 | 0 | PUT | 0 | 0 | 188.69 | TRUE | 0 | 0 |
2025-04-17 | 2.5 | 1.4 | PUT | 10 | 0 | 0 | TRUE | 1.4 | 0 |
2025-04-17 | 5 | 0 | PUT | 0 | 0 | 442.82 | TRUE | 0 | 0 |
2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 610.71 | TRUE | 0 | 0 |
2025-05-16 | 0.5 | 0 | CALL | 0 | 0 | 346.21 | TRUE | 0 | 0 |
2025-05-16 | 1 | 0 | CALL | 0 | 0 | 270.51 | TRUE | 0 | 0 |
2025-05-16 | 1.5 | 0 | CALL | 0 | 0 | 219.38 | TRUE | 0 | 0 |
2025-05-16 | 2 | 0.3 | CALL | 0 | 12 | 206.93 | FALSE | 0 | 0 |
2025-05-16 | 2.5 | 0.7 | CALL | 0 | 14 | 217.06 | FALSE | 0 | 0 |
2025-05-16 | 5 | 0.25 | CALL | 0 | 33 | 427.81 | FALSE | 0 | 0 |
2025-05-16 | 7.5 | 0.1 | CALL | 0 | 15 | 493.02 | FALSE | 0 | 0 |
2025-05-16 | 0.5 | 0 | PUT | 0 | 0 | 224.64 | FALSE | 0 | 0 |
2025-05-16 | 1 | 0.2 | PUT | 0 | 1 | 204.34 | FALSE | 0 | 0 |
2025-05-16 | 1.5 | 0.35 | PUT | 10 | 0 | 174.66 | FALSE | 0.35 | 0 |
2025-05-16 | 2 | 0 | PUT | 0 | 0 | 200.19 | TRUE | 0 | 0 |
2025-05-16 | 2.5 | 1.15 | PUT | 0 | 21 | 267.29 | TRUE | 0 | 0 |
2025-05-16 | 5 | 2.35 | PUT | 0 | 1 | 220 | TRUE | 0 | 0 |
2025-05-16 | 7.5 | 5 | PUT | 0 | 6 | 309.53 | TRUE | 0 | 0 |
2025-08-15 | 0.5 | 0 | CALL | 0 | 0 | 200.64 | TRUE | 0 | 0 |
2025-08-15 | 1 | 0 | CALL | 0 | 0 | 156.82 | TRUE | 0 | 0 |
2025-08-15 | 1.5 | 0 | CALL | 0 | 0 | 156.84 | TRUE | 0 | 0 |
2025-08-15 | 2 | 0 | CALL | 0 | 0 | 146.67 | FALSE | 0 | 0 |
2025-08-15 | 2.5 | 0.46 | CALL | 0 | 70 | 152.8 | FALSE | 0 | 0 |
2025-08-15 | 5 | 0.05 | CALL | 0 | 39 | 210.89 | FALSE | 0 | 0 |
2025-08-15 | 7.5 | 0.55 | CALL | 0 | 110 | 228.53 | FALSE | 0 | 0 |
2025-08-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-08-15 | 1 | 0 | PUT | 0 | 0 | 163.13 | FALSE | 0 | 0 |
2025-08-15 | 1.5 | 0.6 | PUT | 3 | 1 | 178.89 | FALSE | 0.6 | 0 |
2025-08-15 | 2 | 0 | PUT | 0 | 0 | 160.84 | TRUE | 0 | 0 |
2025-08-15 | 2.5 | 1 | PUT | 0 | 66 | 154.84 | TRUE | 0 | 0 |
2025-08-15 | 5 | 2.75 | PUT | 0 | 6 | 176.17 | TRUE | 0 | 0 |
2025-08-15 | 7.5 | 0 | PUT | 0 | 0 | 174.64 | TRUE | 0 | 0 |
2025-11-21 | 2.5 | 0.5 | CALL | 9 | 0 | 146.41 | FALSE | 0.5 | 0 |
2025-11-21 | 5 | 0 | CALL | 0 | 0 | 186.12 | FALSE | 0 | 0 |
2025-11-21 | 7.5 | 0 | CALL | 0 | 0 | 195.39 | FALSE | 0 | 0 |
2025-11-21 | 2.5 | 0 | PUT | 0 | 0 | 173.42 | TRUE | 0 | 0 |
2025-11-21 | 5 | 0 | PUT | 0 | 0 | 152.48 | TRUE | 0 | 0 |
2025-11-21 | 7.5 | 0 | PUT | 0 | 0 | 142.74 | TRUE | 0 | 0 |
Latest CTXR Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 110 | $0.9501 |
Jun 13, 2022 7:59 PM EST | 1000 | $0.9501 |
Jun 13, 2022 7:59 PM EST | 200 | $0.95 |
Jun 13, 2022 7:59 PM EST | 100 | $0.9501 |
Jun 13, 2022 7:59 PM EST | 73 | $0.9501 |
Citius Pharmaceuticals, Inc (CTXR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020015902/0001213900-20-015902-index.htm |
2020-04-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1506251/000000000020003314/0000000000-20-003314-index.htm |
2020-06-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1506251/000000000020005207/0000000000-20-005207-index.htm |
2020-09-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1506251/000000000020008820/0000000000-20-008820-index.htm |
2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1506251/000091957420000776/0000919574-20-000776-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1506251/000091957420001645/0000919574-20-001645-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390019020117/0001213900-19-020117-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390019020119/0001213900-19-020119-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390019020122/0001213900-19-020122-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390019020124/0001213900-19-020124-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390019020126/0001213900-19-020126-index.htm |
2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390019021804/0001213900-19-021804-index.htm |
2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390019022028/0001213900-19-022028-index.htm |
2019-12-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1506251/000121390019026259/0001213900-19-026259-index.htm |
2019-12-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1506251/000121390019026269/0001213900-19-026269-index.htm |
2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390019026521/0001213900-19-026521-index.htm |
2019-12-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1506251/000121390019026699/0001213900-19-026699-index.htm |
2019-12-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1506251/000121390019026703/0001213900-19-026703-index.htm |
2020-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020001566/0001213900-20-001566-index.htm |
2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020002349/0001213900-20-002349-index.htm |
2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020002480/0001213900-20-002480-index.htm |
2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020003094/0001213900-20-003094-index.htm |
2020-02-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020003577/0001213900-20-003577-index.htm |
2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020003992/0001213900-20-003992-index.htm |
2020-02-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020004157/0001213900-20-004157-index.htm |
2020-02-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020004160/0001213900-20-004160-index.htm |
2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020004257/0001213900-20-004257-index.htm |
2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020004698/0001213900-20-004698-index.htm |
2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020008291/0001213900-20-008291-index.htm |
2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020008765/0001213900-20-008765-index.htm |
2020-04-10 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1506251/000121390020008985/0001213900-20-008985-index.htm |
2020-04-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1506251/000121390020009473/0001213900-20-009473-index.htm |
2020-04-24 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020010056/0001213900-20-010056-index.htm |
2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020010246/0001213900-20-010246-index.htm |
2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020010431/0001213900-20-010431-index.htm |
2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020011769/0001213900-20-011769-index.htm |
2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020012286/0001213900-20-012286-index.htm |
2020-05-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020012584/0001213900-20-012584-index.htm |
2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020012809/0001213900-20-012809-index.htm |
2020-05-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020012897/0001213900-20-012897-index.htm |
2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020013443/0001213900-20-013443-index.htm |
2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020013937/0001213900-20-013937-index.htm |
2020-06-05 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1506251/000121390020014231/0001213900-20-014231-index.htm |
2020-06-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1506251/000121390020014691/0001213900-20-014691-index.htm |
2020-06-12 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020014875/0001213900-20-014875-index.htm |
2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020015902/0001213900-20-015902-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017075/0001213900-20-017075-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017080/0001213900-20-017080-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017083/0001213900-20-017083-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017086/0001213900-20-017086-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017089/0001213900-20-017089-index.htm |
2020-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017179/0001213900-20-017179-index.htm |
2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017402/0001213900-20-017402-index.htm |
2020-07-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017556/0001213900-20-017556-index.htm |
2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020017558/0001213900-20-017558-index.htm |
2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020020036/0001213900-20-020036-index.htm |
2020-08-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020020405/0001213900-20-020405-index.htm |
2020-08-05 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1506251/000121390020020409/0001213900-20-020409-index.htm |
2020-08-06 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1506251/000121390020020467/0001213900-20-020467-index.htm |
2020-08-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020020900/0001213900-20-020900-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020021164/0001213900-20-021164-index.htm |
2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020022331/0001213900-20-022331-index.htm |
2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020023749/0001213900-20-023749-index.htm |
2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020023818/0001213900-20-023818-index.htm |
2020-09-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1506251/000121390020026248/0001213900-20-026248-index.htm |
2020-09-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020026724/0001213900-20-026724-index.htm |
2020-09-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1506251/000121390020027371/0001213900-20-027371-index.htm |
2020-09-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020027841/0001213900-20-027841-index.htm |
2020-09-25 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1506251/000121390020028490/0001213900-20-028490-index.htm |
2020-09-25 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1506251/000121390020028494/0001213900-20-028494-index.htm |
2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020028857/0001213900-20-028857-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030788/0001213900-20-030788-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030790/0001213900-20-030790-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030791/0001213900-20-030791-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030792/0001213900-20-030792-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030793/0001213900-20-030793-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030794/0001213900-20-030794-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030795/0001213900-20-030795-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030797/0001213900-20-030797-index.htm |
2020-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020030802/0001213900-20-030802-index.htm |
2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1506251/000121390020033152/0001213900-20-033152-index.htm |
2020-04-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1506251/999999999520000856/9999999995-20-000856-index.htm |
2020-06-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1506251/999999999520001419/9999999995-20-001419-index.htm |
2020-09-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1506251/999999999520002581/9999999995-20-002581-index.htm |
2020-09-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1506251/999999999520002620/9999999995-20-002620-index.htm |